Series D - ElevateBio
Investment Firm
Overview
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Announced Date
May 24, 2023
Closed on Date
May 24, 2023
Funding Type
Series D
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
11
Round Details and Background
ElevateBio raised $401000000 on 2023-05-24 in Series D
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 30, 2020 |  Series B - ElevateBio | 9 | - | 170.0M |
| Jan 01, 2018 | Series A - ElevateBio | 1 | - | undefined |
| Mar 15, 2021 | Series C - ElevateBio | 14 | - | 525.0M |
| May 24, 2023 | Series D - ElevateBio | 16 | - | 401.0M |
Recent Activity
There is no recent news or activity for this profile.